Narsico, Rosie S.
HRN: 10-92-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
CEFTRIAXONE 1G (VIAL)
05/22/2026
05/28/2026
IV
1g
Q12h
CAP-MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines